Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.

Single-use and reusable needle-free injection devices will be designed for precise self-administration and home use. PharmaJet injector pens are intended for needle-free subcutaneous delivery of a ...

Credit: Getty Images. Endo’s product is the only ready-to-use formulation of bivalirudin currently on the market. Endo International has announced the launch of Bivalirudin Injection in a ready-to-use ...